Abstract
To explore the relationship between gut microbiota and the development of type 2 diabetes (T2DM), this study analyzed 121 subjects categorized by glucose intolerance status: normal glucose tolerance (NGT), prediabetes (Pre-DM), and newly diagnosed T2DM. Using 16S rDNA-based high-throughput sequencing, researchers observed T2DM-related dysbiosis, including distinct microbial community separation and shifts in alpha diversity. Significant associations were found between metabolic parameters (FPG, CRP) and gut microbiota structure. Notably, beneficial butyrate-producing bacteria were more abundant in healthy subjects, while Bacteroides levels were halved in the T2DM group. These findings suggest that structural modulation of the gut microbiota is an early event in the pathogenesis of diabetes.
Introduction
While genetics and lifestyle are established drivers of Type 2 Diabetes (T2DM), the gut microbiome—the complex ecosystem of trillions of bacteria in the digestive tract—has emerged as a critical contributor to metabolic health. Most existing research focuses on the microbiome after a T2DM diagnosis has already been made. This study investigates the "dynamic development" of the disease, comparing healthy individuals (NGT), those with prediabetes (Pre-DM), and newly diagnosed diabetics to determine if gut alterations are a consequence of the disease or an early warning sign appearing during the progression of glucose intolerance.
Methods
The study involved 121 subjects in Beijing, China, divided into three groups based on WHO criteria: NGT (n=44), Pre-DM (n=64), and T2DM (n=13).
- Sequencing: High-throughput 16S rDNA sequencing (targeting the V3–V5 regions) was performed on fecal samples.
- Bioinformatics: Data were processed using Mothur for noise reduction and CD-HIT for clustering into Operational Taxonomic Units (OTUs) at 97% similarity.
- Statistical Analysis: Alpha diversity was measured using Chao1 and Shannon indices. Co-inertia Analysis (CIA) and PERMANOVA were employed to correlate microbial clusters with clinical markers like fasting plasma glucose (FPG) and C-reactive protein (CRP).
Results and Discussion
Microbial Community Shifts and Dysbiosis
The study revealed that microbial "dysbiosis"—a breakdown in the balance of the gut community—begins as early as the prediabetic stage. Co-inertia Analysis (CIA) demonstrated a separation of microbial communities across the three groups, with specific genera like Prevotella, Roseburia, and Bacteroides driving these shifts.
Diversity and Metabolic Health
A clear trend was observed in microbial diversity. As glucose intolerance progressed, overall diversity tended to decrease. Specifically, a negative correlation was found between fasting insulin (FINS) levels and the Chao1 diversity index, suggesting that insulin resistance is associated with a less diverse and potentially more fragile gut ecosystem.
Key Biomarkers and Butyrate Production
Healthy (NGT) individuals exhibited significantly higher levels of beneficial butyrate-producing bacteria, such as Akkermansia muciniphila and Faecalibacterium prausnitzii. Butyrate is a short-chain fatty acid known for its anti-inflammatory properties and its role in maintaining gut barrier integrity. Conversely, the abundance of Bacteroides in the T2DM group was only half that of the NGT and Pre-DM groups. The class Verrucomicrobiae was also identified as a potential biomarker, showing significantly lower abundance in both Pre-DM and T2DM groups.
Conclusion
This research provides evidence that the structural modulation of gut microbiota is an early event in the progression toward Type 2 Diabetes. The loss of beneficial, butyrate-producing bacteria and the overall decline in microbial diversity during the prediabetic stage suggest that the microbiome could serve as a diagnostic tool for early intervention. While limited by a small T2DM sample size and a cross-sectional design, these findings underscore the importance of the gut-metabolism axis in human health.
Summary updated